Patent · US Active

Haptens of aripiprazole

US9504682B2 · kind B2 · utility

17Cited by

4References

13Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Ronghui Lin · Ambler, US
Rhys Salter · Doylestown, US
Thomas R. DeCory · Pittsford, US
Eric Hryhorenko · Hilton, US
Bart M. Remmerie · Evergem, BE
Banumathi Sankaran · Lexington, US

Key dates

Filing date	Aug 20, 2013
Grant date	Nov 29, 2016
Priority date	—
Expiry date	Nov 20, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/6081
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of Formula I, wherein R1, R2, and R3 are defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.